Davorka Tomic

Featured in: Favicon

sagepub.com Favicon

neurology.org Favicon

futuremedicine.com Favicon

journals.sagepub.com

Articles

A plain language summary of what clinical studies can tell us about the safety of evobrutinib – a potential treatment for multiple sclerosis | Neurodegenerative Disease Management

Jun 22, 2023 | futuremedicine.com | Xavier Montalban |Daniel Wallace |Mark C Genovese |Davorka Tomic

Neurodegenerative Disease ManagementAhead of PrintPlain Language Summary of PublicationOpen AccessAbstractWhat is this summary about? This summary explains the findings from a recent investigation that combined the results of over 1000 people from three clinical studies to understand the safety of evobrutinib. Evobrutinib is an oral medication (taken by mouth), being researched as a potential treatment for multiple sclerosis (MS).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →